Found: 3
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2023 · pp. 43–50
Mitrofanova L.B., Rasulov Z.M., Vorobieva O.M., Gorshkov A.N., Sterkhova K.A., Ulitin A.Yu
Cortical dyslamination with neuronal dysmorphism that occurs adjacent to an arteriovenous malformation (AVM) and is accompanied by epilepsy (E) is classified as FCD IIIc. Its etiology and pathogenesis have yet to be determined. Objective: to clarify the cellul…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020
Galkovsky B.E., Mitrofanova L.B., Gulyaev D.A. Lakhina Y. S., Osipov Y.S.
Currently, glioblastoma is an extremely malignant tumor, for which treatment only temozolomide is relatively effective. Aim to study the expression and variants of coexpression of transcription factors NeuroD1, Prox1, FoxM1, somatostatin receptors of the 2nd a…
Research article2014
Moskaleva E.Yu., Semochkina Yu.P., Rodina A.V., Severin S.E.
Targeted delivery of anticancer drugs is a new direction aimed to delivery preparations capable of enhancing selectivity of action of drugs owing to the use of vector molecules. Targeted drug delivery system is the construction that includes three components: …